PubMed HealthSearch

Biomedical subjects

Y Mitamura

Publications and source records attributed to Y Mitamura.

At least 19 recordsLinked to original sources

Investigation of parameter estimator and adaptive controller for assist pump by computer simulation.

The multi-output adaptive controller of a left ventricular assist device (LVAD) was studied by computer simulation. The controller regulated two outputs--mean aortic pressure (mAoP) and mean atrial pressure (mLAP)--by regulating vacuum pressure (input). The autoregressive models were used to describe the circulatory system. The parameters of the models were estimated by the recursive least squares method. Based on the autoregressive models, the vacuum pressure minimizing a performance index was searched. The index used was the weighted summation of the square errors. Responses of the adaptive controller were simulated when the contractility of the left ventricle was decreased at various rates and the peripheral resistance was changed. Both the mAoP and mLAP were controlled to their predicted values in the steady state. The steady-state errors of the mAoP were less than a few mm Hg, and those of the mLAP were lower than 1 mm Hg. Consequently, the estimated parameters can be regarded as true parameters, and the adaptive controller has the potential to control more than two outputs. The multioutput adaptive controller studied is useful in controlling the LVAD according to the change in circulatory condition.

Aorta, Thoracic

Development of an implantable motor-driven assist pump system.

A motor-driven artificial pump and its transcutaneous energy transmission (TET) system have been developed. The artificial pump consists of a high-speed dc brushless motor driving a ball screw and magnetic coupling mechanism between the blood pump and ball screw. The ball screw transfers high-speed rotary motion into low-speed rectilinear motion by a single component. Magnetic coupling enables active blood filling without applying an excess negative pressure to the pump. The transcutaneous transformer is formed from a pair of concave/convex ferrite cores. This design minimizes lateral motion of the external core. Information on motor voltage is transmitted through the skin by infrared pulses. The motor voltage is regulated by controlling the duty ratio of the square pulse supplied to the primary coil. Pump flow of 5.6 l/min was obtained with a mean outlet pressure of 100 mmHg at a drive rate of 100 bpm under preload of 15 mmHg. The performance of synchronous pumping has been very satisfactory. Continuous pumping was maintained by the backup battery in the case of interruption of TET. 24 W were transmitted by TET system with 78 percent of efficiency. Temperature rise of the internal core was 0.2 C. The developed system is promising as an implantable assist pump system.

Animals

Catheter-type defibrillation electrode using glassy carbon: results of electrode implantation.

The implantable defibrillator, developed by Dr Michel Mirowski, is a remarkable electric therapeutic device which has been in clinical use since 1980 in the treatment of life-threatening arrhythmia. However, as the present life span of this device is only 3 years, research is being carried on to extend the lifetime with improved stimulation methods, circuits and electrodes. In particular, the electrode system which is inserted into the right ventricle has more than 50 times the electrode area of a pacing electrode and is prone to degradation. What is needed is biocompatibility and electrical stability, similar to that of cardiac pacemaker electrodes, which can be used for more than 10 years. For this purpose, we focused on a conductive ceramic as a new material for the defibrillation electrode instead of the previously-used metal. We selected glassy carbon as our electrode material and tested the surface condition through acute and chronic animal experiments. No clots formed around the electrodes after a 3-month implantation, nor were there surface disorders after the defibrillation stimulations. We concluded that glassy carbon is a promising material for future defibrillation electrodes.

Animals

Role of physical properties of resistance vessel wall in regulating peripheral blood flow--II. Structural and mechanical behavior.

In order to examine the structural and mechanical properties of the vessel wall resistance when subjected to autoregulatory flow control, a mechanical model for the vascular wall was derived from a mathematical model. The mechanical model was an analogue model which connected in series the Maxwell model (elastic modulus: K3) with the parallel elements of Hill's model (elastic modules: K2) and Hooke's elastic model (elastic modulus: K1); it was also mathematically equivalent to the Spring model (see part I). The structural and mechanical properties of the resistance vessel wall were characterized by the three elastic moduli (K1, alpha K2 and K3) [mmHg]. The parameter alpha was a modification factor of the elastic modulus K2 given by the myogenic mechanism. After a numerical analysis of the experimental data given by the mechanical model, we confirmed that the arterial pressure range for autoregulatory flow controls shifted to the upper region with an increase of the elastic modulus K1 and the flow regulation was reduced.

Animals

Development of a ceramic heart valve.

A durable and thromboresistant ceramic heart valve comprised of a single crystal alumina disk and titanium nitride (TiN) valve ring has been developed. Blood compatibility was examined by scanning electron microscopy (SEM) examinations of the valves implanted in sheep for 35 (#1), 26 (#2), 20 (#3), 23 (#4), and 26 (#5) days. The single crystal alumina and TiN surfaces were free of platelet aggregation or fibrin networks, except for some depositions of fibrin and platelets on the outflow TiN ring in #3, and isolated red cells on the outflow TiN ring in #5. Durability testing under high pressure (1750 mmHg = 233 KPa) pulsatile conditions showed that the safety factor of the ceramic valve was more than seven times greater than anticipated. The ceramic valve is promising as an artificial heart valve.

Animals

Effects of venous pressure elevation on myogenic vasoconstrictive responses to static and dynamic arterial pressures.

In order to establish the nature of the stretch-evoked dynamic properties of vascular smooth muscle in arterioles, we have examined the static and dynamic effects of both arterial pulse pressure and elevated venous pressure on the resistance vessels (arteries and arterioles) in an intestinal mesenteric preparation derived from dogs. The dynamic myogenic response to stretch stimuli was directly related to both the frequency of arterial pulse pressure (1-20 c/min) and the level of venous pressure (0-45 mmHg). Under elevated venous pressure (20 mmHg), the mean arterial flow decreased with an increase in the frequency of arterial pulse pressure. The arteriolar vascular tone (namely, vascular resistance) was seen to be enhanced. We found that elevated venous pressure promotes active constriction (9-53%) of arteriolar smooth muscle (myogenic mechanism). The elevation of venous pressure also caused a rhythmic constriction (vasomotion) in the site of both vein and artery, which was completely abolished by an alpha-blocker (phentolamine). The results suggest that during venous pressure elevation a very pronounced myogenic constriction in terminal arterioles is caused by either a local neural reflex or a propagated myogenic response in the arteriolar network.

Animals

The effect of left ventricular assist device (LVAD) on cardiac reserve in dogs.

The effect of LVAD on the preservation of cardiac reserve against ischemic damage was studied using Sarnoff's ventricular function curve. An LVAD was implanted between the canine left atrium and the aorta. Left ventricular function was measured by changing the height of the reservoir connected to the left atrium. The left ventricular function curve (LVFC) was drawn by plotting left ventricular stroke work (LVSW) against left atrial pressure (LAP). The coronary artery was occluded under a pump-on (ON group) or pump-off (OFF group). After reperfusion, measurements were repeated and changes in the LVFC caused by ischemia were compared in both groups. The gradient of the LVFC was significantly reduced by ischemia (107 +/- 15 ml/beat----80 +/- 14, n = 13) but not in the ON group. LVSW under normal preload did not significantly change in either group. This suggests that the LVAD preserved cardiac reserve against ischemic damage.

Animals

Myocardial oxygen tension during left ventricular bypass.

The effect of an assist pump on the heart was evaluated on the basis that myocardial gas tensions reflect the balance between oxygen supply and consumption in local regions of the myocardium. A left ventricular assist device (LVAD) was implanted in dogs between the left ventricle (LV group), or the left atrium (LA group) and the aorta. The assist pump was driven in a counterpulsation mode. A silicone catheter for mass spectrometry was inserted into the myocardium to monitor continuously myocardial oxygen and carbon dioxide tensions (PmO2, PmCO2). Coronary sinus blood flow (CSBF) was measured by completing an extracorporeal flow loop between the coronary sinus and the jugular vein. During LVAD counterpulsation, the LV pressure was reduced and diastolic arterial pressure (i.e. coronary perfusion pressure) was increased. Total LV bypass was obtained in the LV group, and partial LV bypass in the LA group. In the LV group, PmO2 was 18.3 +/- 1.9 mmHg with pump-off and increased to 26.4 +/- 3.0 during LV bypass (N = 10, p less than 0.005). PmCO2 was 45.3 +/- 1.8 mmHg with pump-off and decreased to 40.2 +/- 1.5 during bypass (N = 10; p less than 0.005). CSBF significantly decreased during LV bypass from a control value of 24.1 +/- 2.74 ml/min/100g to 16.3 +/- 1.69 in LV group (N = 10; p less than 0.001). It was 43.4 +/- 8.0 ml/min/100g in the pump-off and 31.9 +/- 7.2 during LV bypass in the LA group (N = 7; p less than 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)

Animals

Effect of left ventricular assist device (LVAD) on myocardial pH change after regional coronary occlusion.

To evaluate the effect of an assist pump on the metabolic viability of the ischemic myocardium, myocardial pH was continuously monitored using an ion-sensitive field-effect transistor (ISFET) pH sensor in 14 dogs after coronary occlusion. In seven dogs (control group), coronary occlusion (10-20 min) and successive reperfusion (30-60 min) were performed several times. In seven dogs [left ventricular assist device (LVAD) group], the LVAD was implanted between the left atrium and the aorta. Occlusion and reperfusion were performed first with the pump on and then with the pump off. In both groups, myocardial pH fell after occlusion, and increased after reperfusion. In the control group, the fall rate of pH in the later coronary occlusion decreased to 66 +/- 7% (mean +/- SEM) of that in the previous occlusion. Contrarily, in the LVAD group, the fall rate under LVAD-off increased to 174 +/- 32% of that under the preceding LVAD-on. This indicates that progressive cellular damage occurred in the control group, while the myocardium was preserved by the assist pump in the LVAD group. LVAD is effective for preserving the metabolic viability of the ischemic myocardium.

Animals